TAG: GS 3: SCIENCE AND TECHNOLOGY
THE CONTEXT: The emergence of new Covid-19 variants, FLiRT and LB.1, has triggered concerns about a potential resurgence of infections globally.
EXPLANATION:
- These variants, which have shown significant mutations, are driving an increase in Covid-19 cases in the US, UK, and other regions.
Characteristics of FLiRT and LB.1 Variants
- FLiRT Variants
- Group Composition:
- FLiRT is a group of sub-variants of Omicron, including KP.2, JN.1.7, and other variants starting with KP or JN.
- These are descendants of the JN.1 variant, which was dominant in the US during late 2023 and early 2024.
- Symptoms:
- Similar to earlier variants, symptoms include fever, cough, fatigue, and digestive issues.
- Transmission and Immunity Evasion:
- FLiRT variants are highly transmissible and have an enhanced ability to evade immunity from vaccines and previous infections.
- Prevalence:
- Over 60% of Covid-19 cases in the US are attributed to FLiRT variants, with KP.3 alone accounting for 33.1% of infections by early June 2024.
- 1 Variant
- Mutation:1 is a mutation of the FLiRT group, with an additional mutation on the FLiRT strains.
- Prevalence: Responsible for 17.5% of Covid-19 cases in the US as summer began in 2024.
- Infectivity: Preliminary data suggests that LB.1 is poised to be more infectious and transmissible than its predecessors.
- Group Composition:
Current Impact and Concerns
- United States:
- The CDC reported an increase in emergency room visits by over 23% and a rise in Covid-19 deaths by 14.3% from June 16 to 22, 2024.
- The overall share of Covid-19 deaths remains low at 0.8%.
- United Kingdom and Singapore:
- These regions have also seen a significant uptick in cases and hospitalizations.
- In Singapore, cases rose from 13,700 to 25,900 between May 5 to 11, with hospitalizations increasing from 181 to 250 in the same period.
- India:
- As of May 2024, there were 290 cases of the KP.2 variant and 34 cases of the KP.1 variant reported.
Persistence and Evolution of Covid-19
- Since its emergence in late 2019, Covid-19 has continued to mutate and circulate among humans.
- The ongoing mutations, like those seen in the FLiRT and LB.1 variants, contribute to the virus’s persistence despite widespread vaccination and previous infections.
- Immunity from infections or vaccinations typically wanes after four to six months, necessitating continued vigilance and booster doses.
Preventive Measures
- General Precautions:
- Maintain social distancing, use well-fitted respiratory masks such as N95 or KN95 indoors, and increase ventilation in indoor settings.
- Vulnerable Populations:
- Individuals with comorbidities and those in high-infection areas should take extra precautions.
- Continued booster doses of the vaccine are recommended to enhance immunity against current strains.
- Public Health Recommendations:
- The US FDA has urged drug manufacturers to target the new variants in their vaccines, emphasizing the need for updated boosters, particularly for the elderly and immunocompromised individuals.